Skip to main content
main-content

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

Journal of Medical Case Reports 1/2017

Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report

Zeitschrift:
Journal of Medical Case Reports > Ausgabe 1/2017
Autoren:
Linda Sakhri, Julian Pinsolle, Denis Moro-Sibilot, Hélène Pluchart

Background

We present a case of pemetrexed toxicities due to reabsorption by an ileal neobladder that occurred in a 59-year-old white man with wild-type metastatic lung adenocarcinoma. He developed unusually extended aplasia and acute kidney injury after a cycle of cisplatin and pemetrexed. We considered that ileal reabsorption of pemetrexed by the neobladder was responsible for the prolonged hematotoxicity. In fact, ileal mucosa absorption is possible because pemetrexed is partly lipophilic and eliminated in an active form.

Case presentation

We report a case of a 59-year-old white man with a metastatic adenocarcinoma of the lung diagnosed in April 2013. This tumor was EGFR (epidermal growth factor receptor), ALK (anaplastic lymphoma kinase), KRAS (V-Ki ras2 Kirsten rat sarcoma viral oncogene homolog), ERBB2 (erb-b2 receptor tyrosine kinase 2), and B-Raf (V-raf murine sarcoma viral oncogene homolog B1) wild-types. He had a previous history of radical cystectomy, prostatectomy, and vesiculectomy and received a Hautmann neobladder in 2001. The neobladder was constructed from ~ 70 cm of distal ileum, which was anastomosed to his ureters and urethra. He initiated cisplatin and pemetrexed chemotherapy, and a vitamin B12 and folic acid supplementation had been prescribed prior to the initiation of treatment.
After 10 days of chemotherapy he was hospitalized because of fever above 39.9 °C. A blood sample showed neutropenia > 0.3 G/L and thrombocytopenia > 21 G/L. Thus, amoxicillin-clavulanate plus ciprofloxacin treatment was started.
On the 4th day after hospitalization he had acute renal failure, metabolic acidosis, hyponatremia, and hyperchloremia.
An abdominopelvic computed tomography (CT) scan showed major distension of the neobladder and bilateral pyelocaliceal dilatation. Urethral catheterization collected 2 L of a gelatinous liquid.
The electrolyte disorders were corrected by 23 days after hospitalization and his renal function was restored at 16 days of hospitalization (Fig. 1). His neutrophil levels became standardized by 22 days after hospitalization and platelets by 34 days after hospitalization. He received several transfusions with platelets (Figs. 2 and 3).

Discussion

Our patient presented unusual hematological adverse effects after a first cycle of chemotherapy. In patients with an advanced stage of non-small-cell lung cancer, pemetrexed is known to cause grade 3 and 4 neutropenia in 15% of cases, grade 3 and 4 thrombocytopenia in 4% of cases [1], and all grades of acute renal failure in 2.4% of cases [2]. In contrast, cisplatin can cause anemia [3], but medullary aplasia is rarely described after only cisplatin [4].
It is to be noted that in patients with locally advanced or metastatic bladder cancer treated with pemetrexed, the hematotoxicity rate is more significant so that cases of grade 3 to 4 neutropenia are up to 75% [510]. The hematotoxicity seems more important in patients who had cystectomy. Another study, testing intravesical injections of pemetrexed in pigs, highlighted no myelosuppression and no systemic absorption [11].
Because of the hydrophilicity and the low oral bioavailability of cisplatin, it can be assumed that cisplatin was not absorbed by the ileal mucosa. In a phase I study of pemetrexed, 78% of the administrated dose was found in its active form within the urine. Its plasma half-life is ~ 3.1 hours when renal function is normal [12].
During our patient’s urine-retention episode, we supposed that pemetrexed was stored in an active form by the ileal neobladder due to its lipophilic nature, which maintains toxicities. Cisplatin could not have caused this prolonged toxicity because of its hydrophilicity and so could not be reabsorbed by the ileal mucosa.

Conclusions

Pemetrexed was the main cause of the adverse effects observed because of its absorption by the ileal neobladder, with this being exacerbated by our patient’s urinary retention.
It was not possible to determine the plasma and urine concentrations of pemetrexed as these techniques are not routinely validated.

Acknowledgements

Not applicable.

Funding

None.

Availability of data and materials

Available.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

e.Med Allgemeinmedizin

Kombi-Abonnement

Mit e.Med Allgemeinmedizin erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der allgemeinmedizinischen Zeitschriften, inklusive einer gedruckten Allgemeinmedizin-Zeitschrift Ihrer Wahl.​​​​​​​​​​​​​​

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2017

Journal of Medical Case Reports 1/2017 Zur Ausgabe